HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Stands By Iberogast As German Court Investigates Manslaughter Case

Executive Summary

Bayer's Iberogast is in the spotlight in Germany. According to media reports, a German court is investigating a 2018 Iberogast-related death as a possible case of manslaughter and bodily harm caused by negligence. Bayer is standing behind its product, stating that the death was “most probably” due to an “idiosyncratic reaction.”  

You may also be interested in...



Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast

Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines. 

Bayer Hopes Consumer Health Woes Are In Rear View Mirror As Business Returns To Growth

Bayer is starting to see green shoots of recovery after a prolonged period of declining sales and earnings at its Consumer Health business. Turnover improved by 2% in the second quarter, driven by gains in Europe and Latin America. 

Pascoe offers Iberogast alternative

Natural medicines specialist Pascoe Naturmedizin is positioning in the German market its Pascoventral herbal gastrointestinal liquid as a non-celandine alternative to Bayer Consumer Health’s Iberogast, which has been recently hit by controversy in the country.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel